Related Experiment Video
Updated: Jul 4, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Immunotherapy for metastatic prostate cancer.
1Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA. drakech@jhmi.edu <drakech@jhmi.edu>
Urologic Oncology
|July 3, 2008
Summary
Immunotherapy offers a promising, well-tolerated alternative for metastatic prostate cancer, particularly for asymptomatic patients. Combining immunotherapy with other treatments may maximize survival benefits.
Area of Science:
- Oncology
- Immunology
- Urology
Background:
- Docetaxel chemotherapy is standard for metastatic prostate cancer, improving survival but with limited response rates (40-45%).
- Early detection of prostate cancer reveals asymptomatic metastatic disease, where chemotherapy side effects are detrimental.
- Nontoxic, early treatment options are needed to improve survival and quality of life for these patients.
Purpose of the Study:
- To review immunotherapy mechanisms for metastatic prostate cancer.
- To focus on active immunotherapy strategies.
- To highlight current approaches, ongoing trials, and their advantages/disadvantages.
Main Methods:
- Review of existing literature and clinical trials on immunotherapy for metastatic prostate cancer.
- Focus on active immunotherapy mechanisms, distinguishing from anti-tumor antibodies.
- Analysis of combination strategies including immunotherapy with chemotherapy or hormonal therapy.
Main Results:
- Immunotherapy has shown survival benefits in clinical trials for metastatic prostate cancer.
- Immunotherapy agents are generally well-tolerated, with fewer side effects than chemotherapy.
- Combination therapies (immunotherapy + immunotherapy, or immunotherapy + chemotherapy/hormonal therapy) are under investigation.
Conclusions:
- Immunotherapy is a viable, well-tolerated approach for metastatic prostate cancer.
- Combining distinct immunotherapy strategies or combining immunotherapy with chemotherapy/hormonal therapy may enhance survival outcomes.
- Further research and clinical trials are crucial to optimize immunotherapy use in prostate cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...